Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer


Ris-Rez cuts progression risk by 67% in Phase III relapsed osteosarcoma trial


FDA approves subcutaneous SKYRIZI induction regimen for Crohn’s disease


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Smart machine learning solution to master industry 4.0 in biopharma

Presented by Moritz von Stosch, PhD,
11th November 2020


Innovative solutions from Industry 4.0

Presented by Michael May, PhD, President and CEO, CCRM at Centre For Commercialization Of Regenerative Medicine and Philip G. Vanek, PhD, General Manager, Cell and Gene Therapy Strategy at GE
10th June 2019


Platform technology development for biosimilar upscaling

Presented by Dr H. Fai Poon, President, QuaCell Biotech Ltd and Floris De Smet, Sartorius Stedim Biotech
21st June 2018


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia